IT'S TIME TO BRING A LOT OF PRODUCTION BACK HOME, NOT JUST DRUGS

WASHINGTON, D.C., March 27, 2020 (LifeSiteNews) — A United States senator pleaded with her colleagues to end the country’s dangerous reliance on Chinese drug production by bringing pharmaceutical manufacturing back into the United States of America.

Sen. Marsha Blackburn (R-Tenn.) delivered a sobering presentation, urging her colleagues to join in supporting a measure — aptly named the “Securing America’s Medicine Cabinet Act” — which aims to free the U.S. from China’s stranglehold on the supply chain for many important drugs.

Not only did Blackburn note the Chinese communist government’s current “gross malfeasance” in its handling of its coronavirus outbreak, downplaying the severity of COVID-19 and denying the risk of person-to-person transmission; she also called attention to a long history of the Chinese pharmaceutical industry supplying the U.S. with substandard — sometimes deadly — medicines.

Speaking from the floor of the Senate chamber on Wednesday, Blackburn declared in no uncertain terms that our country’s relationship with China needs to change.

“Americans deserve better than this from their pharmaceutical supply chain. If we allow this to continue, we are going to do so at our own peril,” said Blackburn.

“I encourage my colleagues to support the bipartisan Securing America’s Medicine Cabinet Act,” urged the Tennessee senator.